Literature DB >> 7785319

Receptor proteins on newborn Balb/c mouse brain cells for coxsackievirus B3 are immunologically distinct from those on HeLa cells.

R Xu1, J G Mohanty, R L Crowell.   

Abstract

Newborn Balb/c mice are highly susceptible to infection by the six coxsackievirus serotypes of group B (CVB) and it is known that receptor for these viruses are in highest concentration in the brain as compared to other tissues. Therefore, proteins from the brain tissues of these animals were solubilized (Brain-Ext) and characterized for the identification of mouse brain receptor (MBR) proteins. Virus-blot analyses of Brain-Ext suggested that each of three virus variants of CVB3-(N, W and RD) recognized four receptor proteins designated p46, p44, p36 and p33 according to their molecular size. Similar analyses of cultured neurons from newborn Balb/c mice revealed the presence of the same four receptor proteins, while astrocytes appeared to possess only p46 and/or p44. Isoelectric focusing of Brain-Ext, focused MBR proteins in the pH range 4.0-8.5, with a peak around pH 5.7. P46 was found to be neuraminidase sensitive. A polyclonal rat antiserum (anti-MBR) protected cultured neurons and astrocytes against infection by CVB3, inhibited virus binding to these cells and recognized the same four receptor proteins on western-blots as detected on virus-blots by CVB3. However, a rabbit polyclonal anti-HeLa cell antiserum, which strongly binds to HeLa cells and protects them from CVB3 infection, neither recognized any of the receptor proteins in western-blot analyses of Brain-Ext nor inhibited CVB3 infection on cultured neurons and astrocytes. Conversely, anti-MBR did not recognize any of the receptor proteins by western-blot analysis of HeLa cell extracts nor did it inhibit CVB3 infection of HeLa cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785319     DOI: 10.1016/0168-1702(94)00100-q

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers.

Authors:  S Lecollinet; F Gavard; M J E Havenga; O B Spiller; A Lemckert; J Goudsmit; M Eloit; J Richardson
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

2.  Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.

Authors:  U R de Verdugo; H C Selinka; M Huber; B Kramer; J Kellermann; P H Hofschneider; R Kandolf
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.

Authors:  R P Tomko; R Xu; L Philipson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

4.  The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses.

Authors:  J M Bergelson; A Krithivas; L Celi; G Droguett; M S Horwitz; T Wickham; R L Crowell; R W Finberg
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 5.  High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.

Authors:  Ana Ricobaraza; Manuela Gonzalez-Aparicio; Lucia Mora-Jimenez; Sara Lumbreras; Ruben Hernandez-Alcoceba
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

6.  Expression and distribution of the receptors for coxsackievirus B3 during fetal development of the Balb/c mouse and of their brain cells in culture.

Authors:  R Xu; R L Crowell
Journal:  Virus Res       Date:  1996-12       Impact factor: 3.303

Review 7.  Animal virus receptors.

Authors:  L Jindrák; L Grubhoffer
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.